Alnylam Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Alnylam Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alnylam Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alnylam Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Alnylam Pharmaceuticals Inc (Alnylam Pharmaceuticals) is a biopharmaceutical company with focus on the development and sale of innovative medicines based on RNA interference (RNAi). The company’s focus on R&D activities, geographical presence, and lead product Onpattro are its major strengths, even as a history of operating losses could be a cause for concern. The company could benefit from market potential for hemophilia, regulatory approvals, and strong product pipeline. However, its performance could be affected by competitive environment, government regulations, and uncertain R&D outcomes.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer